Sign in
4

Changes in Ownership

Intellia Therapeutics, Inc. Filed Acc 0001209191-21-009083

President and CEO sold 50,985 shares at an average $71.70 ($3,655,410)

  • President and CEO acquired 96,718 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LEONARD JOHN M · President and CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-05 Exercise or conversion : show line 1 in the form +40,000 $13.40 $536,000 654,803 D
2021-02-05 Sale : show line 2 in the form −8,043 $67.18 $540,329 646,760 D
2021-02-05 Sale : show line 3 in the form −14,018 $67.86 $951,261 632,742 D
2021-02-05 Sale : show line 4 in the form −881 $68.78 $60,595 631,861 D
2021-02-09 Exercise or conversion : show line 5 in the form +56,718 $6.83 $387,384 688,579 D
2021-02-09 Sale : show line 6 in the form −28,043 $75.00 $2,103,225 660,536 D
Open-market sales · 50,985 sh · avg $71.70 · $3,655,410

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-02-05 Exercise or conversion : show line 7 in the form Stock Option (right to buy) −40,000 285,453 D
2021-02-09 Exercise or conversion : show line 8 in the form Stock Option (right to buy) −56,718 68,516 D
Loading xslF345X03/doc4.xml…